The Signal

Expert insights and opinions on clinical research and drug development.

Expert insights and opinions on clinical research and drug development.

Author: Signant Health

eConsent Task Force Co-Chaired by Signant and Medidata Honored as Finalists for TOPRA Innovation Award

In 2019, a team of industry experts formed a task force to examine challenges and opportunities in the adoption of…

3 Reasons Oncology Studies Should Consider a Pre-Configured eCOA Solution

The FDA’s recent guidance placed an increased emphasis on patient-reported outcome measures (PROMs) for oncology trials. This data provides better insight into the patients’ disease-related symptoms, side effects of treatment, and effect…

Direct-to-Patient Clinical Supply Distribution: Everything You Need to Know

The adoption of decentralized studies has rapidly increased thanks in part to the recent pandemic, which encouraged regulators to permit more flexibility within protocols and forced sponsors to implement…

The Inaugural IMAGINE FORUM Recap

At Signant Health, we believe progress is best done together. That’s why we launched the Imagine Forum to promote industry-wide collaboration and thoughtful discussion.  …

AAIC Post Event Blog

Here are a few takeaways from Signant’s presentations that you may have missed: Dr. Miller led a product showcase, Glimmers…

Best Practices: RTSM Strategies to Avoid Partially Unblinding Clinical Trials

Randomization and Trial Supply Management (RTSM) solutions are routinely used in today’s clinical trials to manage randomization, enable emergency code break to…

Preparing Study Staff, Sites, and Patients for Remote Video Assessments and Consultations

With the proliferation and widespread acceptance of telemedicine solutions in clinical research, it is imperative to properly prepare everyone involved in a study to…